All In Biotech

Drug Trial Radar · NCT05265338

A Food Effect Study of KC1036 in Healthy Subjects

A Phase I Study of KC1036 on Pharmacokinetics to Assess the Effect of High Fat Diet in Chinese Adult Healthy Subjects.

Last checked: Nov 19, 2026Latest source record: Oct 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Mar 10, 2022

Primary completion

Mar 23, 2022

Study completion Mar 23, 2022

Sponsor

Sponsor type
Industry
First posted
Mar 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of the study was to assess the effect of High Fat Diet on the pharmacokinetics of KC1036 in Chinese adult healthy subjects.

Conditions

  • Healthy Subjects

Interventions

  • KC1036Drug

    60mg QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (PK) profile: CmaxTime frame: up to 13 Days
  2. Pharmacokinetics (PK) profile: TmaxTime frame: up to 13 Days
  3. Pharmacokinetics (PK) profile: T1/2Time frame: up to 13 Days
  4. Pharmacokinetics (PK) profile: AUCTime frame: up to 13 Days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.